| |
|
|
|
Alpine Immune Sciences Inc  
|
|
8.01 0 (0%) |
10-21 16:00 |
|
Open: |
8.051 |
Pre close: |
8.01 |
Target:
|
10.11
|
|
High: |
8.3 |
Low: |
7.8118 |
Resistance:
|
8.66
9.46
|
|
Volume: |
33,767 |
Market Cap: |
191M |
Support:
|
7.36
6.12
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
8.40
 |
MACD |
MACD(12,26):
|
-0.03 |
|
MA(20): |
8.57  |
Signal(12,26,9): |
0.04 |
|
MA(100): |
8.56 |
Stochastic Oscillator |
%K(14,3):
|
23.00 |
|
MA(250): |
5.31 |
%D(3): |
37.06 |
|
Average Volume(K) |
3-Month: |
6076
|
52-Week |
High:
|
15.00 |
|
10-Days: |
3749 |
Low: |
2.05 |
|
RSI |
RSI(14):
|
41.43 |
Change(%): |
179.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.780 |
Return on Equity (ttm) |
-107.3 |
Shares Out. (M) |
23.78 |
|
EPS Est. Current Year |
-3.180 |
Return on Assets (ttm) |
-24.6 |
Shares Float (M) |
8.97 |
|
EPS Est. Next Year |
-2.500 |
PEG Ratio |
0.00 |
% Held by Insiders |
40.52 |
|
EPS Est. Next Quarter |
-1.030 |
Qtrly Rev. Growth |
21.3 |
% Held by Institutions |
44.39 |
|
Forward EPS |
-2.280 |
Gross Profit (p.s.) |
-1.434 |
Shares Short (K) |
8 |
|
Book Value (p.s.) |
0.870 |
EBITDA (p.s.) |
-1.410 |
P/E |
-4.50 |
|
Sales Per Share |
0.124 |
Qtrly Earnings Growth |
0.00 |
P/BV |
9.21 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
28.58 |
P/S |
64.57 |
|
Operating Margin |
-1153.25 |
Levered Free Cash Flow
(M) |
0.52 |
P/CF |
6.66 |
|
|
|
|
|
|
